EP0775202A4 - Human interleukin variants generated by alternative splicing - Google Patents

Human interleukin variants generated by alternative splicing

Info

Publication number
EP0775202A4
EP0775202A4 EP95915509A EP95915509A EP0775202A4 EP 0775202 A4 EP0775202 A4 EP 0775202A4 EP 95915509 A EP95915509 A EP 95915509A EP 95915509 A EP95915509 A EP 95915509A EP 0775202 A4 EP0775202 A4 EP 0775202A4
Authority
EP
European Patent Office
Prior art keywords
alternative splicing
human interleukin
variants generated
interleukin variants
generated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95915509A
Other languages
German (de)
French (fr)
Other versions
EP0775202A1 (en
Inventor
William Alms
Barbara White
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland at Baltimore
Original Assignee
University of Maryland at Baltimore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Maryland at Baltimore filed Critical University of Maryland at Baltimore
Publication of EP0775202A1 publication Critical patent/EP0775202A1/en
Publication of EP0775202A4 publication Critical patent/EP0775202A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP95915509A 1994-03-30 1995-03-30 Human interleukin variants generated by alternative splicing Withdrawn EP0775202A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21983194A 1994-03-30 1994-03-30
US219831 1994-03-30
US22401094A 1994-04-06 1994-04-06
PCT/US1995/004094 WO1995027052A1 (en) 1994-03-30 1995-03-30 Human interleukin variants generated by alternative splicing
US224010 1998-12-31

Publications (2)

Publication Number Publication Date
EP0775202A1 EP0775202A1 (en) 1997-05-28
EP0775202A4 true EP0775202A4 (en) 1999-07-14

Family

ID=26914296

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95915509A Withdrawn EP0775202A4 (en) 1994-03-30 1995-03-30 Human interleukin variants generated by alternative splicing

Country Status (5)

Country Link
EP (1) EP0775202A4 (en)
JP (1) JPH09511400A (en)
AU (1) AU2237395A (en)
CA (1) CA2186854A1 (en)
WO (1) WO1995027052A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2230240C (en) 1995-08-24 2009-08-18 Magainin Pharmaceuticals Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
FR2775984B1 (en) 1998-03-11 2006-09-15 Bioscreen Therapeutics Sa QUALITATIVE DIFFERENTIAL SCREENING
US6881571B1 (en) 1998-03-11 2005-04-19 Exonhit Therapeutics S.A. Qualitative differential screening
US6335426B1 (en) 1996-06-14 2002-01-01 Bayer Corporation T-cell selective interleukin-4 agonists
US5986059A (en) * 1996-06-14 1999-11-16 Bayer Corporation T-cell selective interleukin-4 agonists
US6028176A (en) 1996-07-19 2000-02-22 Bayer Corporation High-affinity interleukin-4 muteins

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CIARDELLI T.L. ET AL.: "Structural sudies of interleukin 2", PEPTIDES: STRUCTURE & FUNCTION: PROCEEDINGS OF THE AMERICAN PEPTIDE SYMPOSIUM. EDS: DEBER C.M., HRUBY V.J., KOPPLE K.D.; PUB: PIERCE CHEMICAL CO, ROCKFORD (IL) USA, vol. 9, 1985, pages 75 - 78, XP002100685 *
See also references of WO9527052A1 *
SORG R. ET AL.: "Expression of alternatively spliced mRNAs for IL-2, IL-4, IL-5, G-CSF, and GM-CSF", SYMPOSIUM ON SECRETED CYTOKINES II; ABSTRACTS OF THE II INTERNATIONAL SYMPOSIUM ON CYTOKINES IN HEMOPOIESIS, ONCOLOGY AND AIDS, HANNOVER 12-22 JUNE 1991, XP002100687 *
SORG R. ET AL.: "Rapid and sensitive mRNA phenotyping for interleukins (IL-1 to IL-6) and Colony-stimulating Factors (G-CSF and GM-CSF) by reverse transcription and subsequent polymerase chain reaction", EXPERIMENTAL HEMATOLOGY, vol. 19, no. 9, 1991, pages 882 - 887, XP002100686 *

Also Published As

Publication number Publication date
JPH09511400A (en) 1997-11-18
AU2237395A (en) 1995-10-23
WO1995027052A1 (en) 1995-10-12
EP0775202A1 (en) 1997-05-28
CA2186854A1 (en) 1995-10-12

Similar Documents

Publication Publication Date Title
GB9425211D0 (en) Substituted 1H-imidazoles
EP0778836A4 (en) Substituted 9-alkyladenines
ZA9533B (en) Pentolifylline therapy
HU9502378D0 (en) Substituted biphenyl-oxazolinones
ZA954027B (en) Interleukin-6 splice variant
EP0775202A4 (en) Human interleukin variants generated by alternative splicing
AU2547895A (en) Therapeutic phenoxyalkylheterocycles
SG73418A1 (en) Novel dihydrodibenzoquinolinediones
GB9402877D0 (en) Mouthwash
ZA952639B (en) Human interleukin variants generated by alternative splicing
PL324647A1 (en) Polyhydroxyalkyl amidobetains
EP0797592A4 (en) Human stanniocalcin-alpha
IL113603A0 (en) Novel substituted benzimidalozes
GB9508640D0 (en) Sunbeds
GB2294422B (en) Ferrule
EP0795006A4 (en) HUMAN MutT2
KR0111970Y1 (en) Goggles
GB9408784D0 (en) Trampoline
GB9420340D0 (en) Therapeutic improvement
GB9404379D0 (en) Therapeutic improvement
HU9400164D0 (en) Kaleidoscope sightmagic
GB9414119D0 (en) Transfection
AU121619S (en) Headband
GB9401456D0 (en) Spacer
AU125030S (en) Spacer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19961028

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: LT;SI

A4 Supplementary search report drawn up and despatched

Effective date: 19990601

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990818